Propanc Biopharma Advances Preparation for PRP Phase 1B Study
Propanc Biopharma is advancing clinical development preparation for a PRP Phase 1B first-in-human study in up to 50 advanced cancer patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Propanc Biopharma Advances Preparation for PRP Phase 1b Cancer Study
Propanc Biopharma said it is advancing clinical-development preparations for a first-in-human PRP Phase 1b study in up to 50 patients with advanced cancer.
Propanc Biopharma Advances Preparation for PRP Phase 1b Cancer Study
Propanc Biopharma said it is advancing preparations for a PRP Phase 1b first-in-human study in up to 50 advanced cancer patients.
Propanc Advances Preparation for PRP Phase 1B Cancer Study
Propanc said it is advancing clinical development preparation for a first-in-human PRP Phase 1B study in up to 50 patients with advanced cancer.